System-based approaches to decode the molecular links in Parkinson's disease and diabetes

Neurobiol Dis. 2014 Dec;72 Pt A:84-91. doi: 10.1016/j.nbd.2014.03.019. Epub 2014 Apr 6.


A growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share remarkably similar dysregulated pathways. It has been proposed that a cascade of events including mitochondrial dysfunction, impaired insulin signaling, and metabolic inflammation trigger neurodegeneration in T2DM models. Network-based approaches have elucidated a potential molecular framework linking both diseases. Further, transcriptional signatures that modulate the neurodegenerative phenotype in T2DM have been identified. Here we contextualize the current experimental approaches to dissect the mechanisms underlying the association between PD and T2DM and discuss the existing challenges toward the understanding of the coexistence of these devastating aging diseases.

Keywords: Inflammation; Insulin resistance; Neurodegeneration; Parkinson's disease; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Biomarkers / blood
  • Databases, Factual
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / metabolism*
  • Disease Models, Animal
  • Humans
  • Mice
  • Models, Genetic
  • Parkinson Disease / complications*
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism*
  • Risk Factors


  • Biomarkers